PDCD1 and lung cancer: In the study by Routy et al. 14 metagenome sequencing analysis in patients with advanced lung, renal, and urothelial cancer, who received anti‐PD1 treatment, showed that, compared with nonresponders, stool cultures from responding lung cancer patients showed significantly higher mucus production.